https://www.facebook.com/627180450809148/

Iswaraj Ramracheya, Floreal, Moka, Terre Rouge, Flacq and Grand Baie, Floréal (2026)

Q: What is the address?

Floreal, Moka, Terre Rouge, Flacq And Grand Baie

19/09/2026

Question from the Audience:
Hi Dr. Are u promoting and encouraging people to have it to lose weight?

Hello. Thank you for your message and for asking. It is actually a very good point to clarify.

The purpose of my post is simply to share medical information and create awareness about these medications, particularly as there is currently so much discussion and interest around GLP-1 receptor agonists and their use for diabetes and weight management.

These medications certainly have a role in the right person, but whether they are appropriate depends very much on each individual’s circumstances, medical history and clinical needs. As with any medication, I would only recommend or prescribe them following an appropriate assessment and when there is a genuine indication.

My aim with these posts is really to help people understand these treatments better, including their benefits, limitations and potential side effects, rather than to encourage anyone to take them.

I hope that clarifies the intention behind the post, and thank you again for giving me the opportunity to explain it. 😊

19/09/2026

ESKI KAN PE PRAN OZEMPIC/MOUNJARO, BIZIN FER REGIME?

Absolutely Yes.
Ozempic works best when it is combined with healthy eating and regular physical activity, but you do not need to follow a very strict diet.

Ozempic and Mounjaro reduces appetite, helps you feel full earlier and keeps you feeling full for longer.

The aim should therefore be to use the reduction in appetite to develop healthier habits: smaller portions, adequate protein, more vegetables and fibre, less highly processed and sugary food, and good hydration.

It is particularly important not to severely restrict food or protein simply to lose weight faster. Rapid weight loss with inadequate nutrition can increase the loss of muscle as well as fat.
Adequate protein and regular exercise, particularly resistance/strength exercise can help preserve muscle.

Semaglutide/Tirzepatide treatment together with lifestyle changes has been associated with improvements in waist circumference, blood pressure, blood glucose, triglycerides and other cardiovascular/metabolic risk factors.

TAKE HOME MESSAGE:
Medication should NOT be viewed as a replacement for healthy eating. Medication can make weight loss easier, but healthy eating and physical activity remain an essential part of successful long-term weight management.

Do not look at it as “Ozempic/Mounjaro OR lifestyle.”
It should be viewed as “Medication AND lifestyle.”

The best approach is appropriate medication + healthy nutrition + physical activity + long-term lifestyle change.

19/09/2026

Ongoing Consultation Schedule:

🗓 Monday pm
📍 Life Together, Forbach
🕗 16:00 - 20:00

📞 260 8181

🗓 Tuesday am
📍 Darne C-Care, Floréal
📞 601 2300 (on appointment only)
⏰ From 07:00 am - 12:00
🗓 Tuesday pm
📍 Royal Green Hospital, Moka
📞 460 6500
⏰ 5:00 pm onwards

🗓 Wednesday
📍 Pharmacy LeHochet, Terre Rouge
📞 249 1716
⏰ 13:00 onwards

🗓 Thursday am
📍 Pharmacy Sante Plus, Goodlands
📞 283 3668
⏰ 08:30 – 12:00 pm
🗓 Thursday pm
📍 Pharmacy Roshni, Flacq
📞 413 2069
⏰ 1:00 pm onwards

🗓 Friday
📍 Royal Green Hospital, Moka
📞 460 6500
⏰ 4:00 pm onwards

🗓 Saturday
📍 C-care Darne, Floréal
📞 601 2300 (on appointment only)
⏰ From 07:00 onwards

🗓️ Sundays
📍 New Life Pharmacy, La Rosa
🕗 09:00 – 13:00
📞 5258 8917
📞 628 1862

Please feel free to get in touch to book an appointment

19/09/2026

OZEMPIC V/S MOUNJARO

Ozempic and Tirzepatide (Mounjaro) are similar, but they are not the same drug.

🔹 Ozempic = semaglutide - acts on one hormone pathway, GLP-1.
🔹 Mounjaro = tirzepatide - has a dual action on GIP + GLP-1 receptors.

Both are once-weekly injections.
They reduce appetite, increase fullness, improve blood glucose and can produce significant weight loss.
Both have a relatively low risk of hypoglycaemia unless combined with insulin or certain diabetes tablets.

In clinical studies, tirzepatide has generally produced greater reductions in both HbA1c and body weight than semaglutide.

• Ozempic: HbA1c reduction around 1–1.5%, with approximately 4–7% weight loss at diabetes doses.
• Tirzepatide: HbA1c reduction around 2–2.5%, with approximately 7–13% weight loss at diabetes doses, depending on dose and duration.

For obesity treatment at the higher doses, substantially greater weight loss can occur with both medications.

Side effects:
Particularly nausea, reduced appetite, diarrhoea, constipation and occasionally vomiting, especially when starting treatment or increasing the dose.

⚠️ Important safety note:
These medications are not suitable for everyone.
They should only be started following an appropriate medical assessment and should be prescribed with proper follow-up. Certain medical conditions, other medications, pregnancy/planning pregnancy and potential adverse effects need to be considered before treatment.
Please do not start, stop, change the dose, or use someone else's medication based on information from social media.

19/09/2026

QUESTION FROM THE AUDIENCE?
Is Ozempic the same as Victoza?

No, Victoza and Ozempic are not the same medication, although they belong to the same family called GLP-1 receptor agonists.

🔹 Victoza = liraglutide – injected once daily
🔹 Ozempic = semaglutide – injected once weekly

Both improve blood sugar, reduce appetite and usually cause some weight loss. However, Ozempic (semaglutide) is generally more potent for both glucose lowering and weight reduction.

In studies of people with type 2 diabetes:

• Victoza typically reduces HbA1c by around 1–1.5 %, with weight loss commonly around 2–5%, depending on the population and duration of treatment.
• Ozempic typically reduces HbA1c by around 1.2–1.8 %, with weight loss often around 4–7% at diabetes doses, although results vary considerably between individuals.

Both have demonstrated cardiovascular benefits in appropriate patients with type 2 diabetes and cardiovascular disease/high cardiovascular risk. They also have a low risk of causing hypoglycaemia when used without insulin or sulphonylureas.

Another practical advantage of Ozempic is that it is taken once weekly rather than every day.

So, although Victoza and Ozempic are related, they are different drugs with different dosing schedules and somewhat different efficacy. The choice should be based on the individual's diabetes control, weight, cardiovascular risk, other medical conditions and treatment goals.

16/09/2026

OZEMPIC - MUCH TALKED ABOUT, BUT OFTEN MISUNDERSTOOD

I recently had the opportunity to contribute to this newspaper article discussing Ozempic (semaglutide) and other similar medications - what it is, how it works, its appropriate medical use, and some of the misconceptions surrounding its increasing popularity.

These medications have brought an important change in the management of type 2 diabetes and obesity, but they are not simply “weight-loss injections” and should not be used casually or without appropriate medical assessment and follow-up.

I hope the article helps provide some clarity on a subject that is receiving considerable attention at present, particularly around who may benefit, the potential side effects, and the importance of using these treatments appropriately and safely.

Sharing it here for those who may find the information useful.

Good medical decisions begin with good information.

11/09/2026

NEW CONSULTATION LOCATION IN THE NORTH

I will be commencing New consultations in the North as from the 14th of September 2026 at:

📍 Life Together, Forbach
🗓️ Mondays
🕗 15:00 - 20:00

Consultations are by appointment.

Please contact Life Together directly to book:
📞 260 8181

11/09/2026

NEW CONSULTATION LOCATION – SOUTH OF MAURITIUS

I wish to inform my patients that I will be commencing consultations in the South of Mauritius from the 13th of September 2026 at:

📍 New Life Pharmacy, La Rosa

🗓️ Sundays
🕗 08:00 – 13:00

Consultations are by appointment.
Please contact New Life Pharmacy directly to book:

📞 5258 8917
📞 628 1862

🚗 On-site parking is available.

This notice is intended to inform patients of the commencement of consultations at this additional location and the relevant consultation arrangements.

07/09/2026

WHERE DO YOU CONSULT?

I currently consult at several locations across Mauritius.
At present, my consultation locations include Royal Green Hospital, Moka on Tuesday pm and Friday pm; C-Care Darné, Floréal on Tuesday am and Saturday am; Pharmacy SantePlus Goodlands on Thursday am; Pharmacy LeHochet Terre Rouge on Wednesday pm; and Pharmacy Roshni Flacq on Thursday pm.

I am also awaiting confirmation of another consultation site in the North (likely to be on Monday pm), and I am currently exploring the possibility of an additional location in the South of the island (likely Sunday am).

Once these arrangements are finalised, I will publish the complete schedule with the respective locations, days, timings and appointment details on this page.

In the meantime, you can send me a message on WhatsApp on 59111128, and I could suggest the closest place for you. Thank you.

06/09/2026

WHO IS Dr ISWARAJ RAMRACHEYA?

Professional Profile

Dr Iswaraj Ramracheya
Consultant in Endocrinology, Diabetes & General Internal Medicine

For those who have recently joined this page, I would like to provide a brief factual introduction to my professional background.

I undertook my postgraduate medical and specialist training in the United Kingdom through the Oxford postgraduate training programme, completing specialist training in Endocrinology & Diabetes, General Internal Medicine and General Practice.

My Professional Qualifications include:
MBBS - Bachelor of Medicine, Bachelor of Surgery
MRCP (UK) - Member of the Royal College of Physicians
MRCP (Endocrinology & Diabetes) - Specialty Certificate in Endocrinology & Diabetes
MRCGP - Member of the Royal College of General Practitioners
FRCP (Lond) - Fellow of the Royal College of Physicians of London
FRCP (Edin) - Fellow of the Royal College of Physicians of Edinburgh
FRCGP - Fellow of the Royal College of General Practitioners
CCT (Endocrinology & Diabetes)
CCT (General Internal Medicine)
CCT (General Practice)

UK Certificates of Completion of Training (CCT)

My professional career has included clinical practice within the United Kingdom and Mauritius, together with involvement in undergraduate and postgraduate medical education, clinical governance and service development.

Iswaraj Ramracheya

19/09/2026

19/09/2026

19/09/2026

19/09/2026

19/09/2026

16/09/2026

11/09/2026

11/09/2026

07/09/2026

06/09/2026

Address

Telephone

Website

Alerts

Shortcuts

Share

Category

Listing takedown request